The RheumNow Week in Review – 28 April 2017 Save

Dr. Jack Cush reviews the news from the last week on RheumNow.com - from the ACR SOTA 2017 meeting in Chicago:

1. ACR abstracts open for submission; Deadline date is June 19; Late breaker deadline is Sept 26. Mark Ur Calendar! https://t.co/gRZ8MRWqXp
2. Congratulations to Dr Jim O'Dell, elected by the ACP as an ACP Masterfor extraordinary career in medicine https://t.co/G9P7LpRr2H
3. EU CHMP recommends the anti-IL6 drug sarilumab (Kevzara; Sanofi) for approval/use in RA. EMA decision awaited. https://t.co/XpHo43Ctyh
4. Sandoz biosimilars of Enbrel and Rituxan were recommened by CHMP for approval/use in the EU. EMA decision awaited https://t.co/zLrPlnKsZF
5. FDA Approves Renflexis as Second Infliximab Biosimilar
6. BSR meeting reports study of 19,162 pts on a biologic shows risk of opportunistic infections to b 1/1000 over 5+yrs https://t.co/ca3F8AZwiq
7. NPF Medical Board review says DMARDs (MTX, CyA,TNFi) can be continued perioperatively in Pso/PsA w/ low risk surgery https://t.co/tfNAxO1W9P
8. 136 pt study; Flares in pregnancy seen in 29% RA & 25% axSpA, 3fold risk if TNFi stopd. Flares mostly Rx w/ Steroids https://t.co/LSapELP240
9. Noninfectious clinically isolated Aortitis may be presentation of GCA, IgG4-related Dz, infectious aortitis or GPA https://t.co/LiTkUS259F
10. WHO study of 31 countries shows RA mortality rates declined 48% from 1987-2011; 7.1 to 3.7/mil-years 1987 fo 2009-11 https://t.co/JyxBsI8ne1
11. Elimination of Senescent Chondrocytes Reduces Post-Traumatic Osteoarthritis 
12. Best to Rehab at Home Following Joint Replacement
13. Pregnancy Flares in RA and Spondylitis